Cargando…

Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy

BACKGROUND: Tumour-infiltrating lymphocytes (TILs) can be used to monitor the immune tumour microenvironment (iTME) and predict treatment response and outcome in breast cancer. We evaluated the prognostic significance of the levels of CD8(+) TILs and forkhead box protein (FOXP3)-positive TILs before...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Wataru, Kashiwagi, Shinichiro, Asano, Yuka, Takada, Koji, Takahashi, Katsuyuki, Hatano, Takaharu, Takashima, Tsutomu, Tomita, Shuhei, Motomura, Hisashi, Ohsawa, Masahiko, Hirakawa, Kosei, Ohira, Masaichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135412/ https://www.ncbi.nlm.nih.gov/pubmed/30233820 http://dx.doi.org/10.1136/esmoopen-2017-000305

Ejemplares similares

Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment
por: Takada, Koji, et al.
Publicado: (2018)

Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
por: Asano, Yuka, et al.
Publicado: (2017)

Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
por: Goto, Wataru, et al.
Publicado: (2017)

Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer
por: Goto, Wataru, et al.
Publicado: (2018)

Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression
por: Asano, Yuka, et al.
Publicado: (2018)

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer
por: Takada, Koji, et al.
Publicado: (2019)

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer
por: Takada, Koji, et al.
Publicado: (2019)

Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment
por: Kashiwagi, Shinichiro, et al.
Publicado: (2018)

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017)

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes
por: Asano, Yuka, et al.
Publicado: (2020)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Alveolar soft part sarcoma metastatic to the breast: a case report
por: Asano, Yuka, et al.
Publicado: (2019)

Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment
por: Goto, Wataru, et al.
Publicado: (2020)

Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report
por: Sera, Tomohiro, et al.
Publicado: (2017)

IgG4-related mastitis requiring differentiation from breast cancer: a case report
por: Asano, Yuka, et al.
Publicado: (2021)

Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report
por: Asano, Yuka, et al.
Publicado: (2019)

Adenoid Cystic Carcinoma of the Breast: A Case Report
por: Kashiwagi, Shinichiro, et al.
Publicado: (2019)

Pathological Complete Response following Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma with Mammary Paget's Disease: A Case Report
por: Goto, Wataru, et al.
Publicado: (2021)

Platelet–Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2016)

Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
por: Takada, Koji, et al.
Publicado: (2020)

The effect of smoking on biological change of recurrent breast cancer
por: Takada, Koji, et al.
Publicado: (2020)

Breast Angiosarcoma with a Preoperative Diagnosis of Late Recurrence of Breast Cancer: A Case Report
por: Kouhashi, Rika, et al.
Publicado: (2021)

Mammary phyllodes tumor with six episodes of a relapse: a case report
por: Iimori, Nozomi, et al.
Publicado: (2017)

Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age
por: Takada, Koji, et al.
Publicado: (2022)

Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
por: Goto, W., et al.
Publicado: (2018)

Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study
por: Kashiwagi, Shinichiro, et al.
Publicado: (2015)

Cowden Syndrome Diagnosed by Bilateral Breast Cancer with Lhermitte-Duclos Disease: A Case Report
por: Morisaki, Tamami, et al.
Publicado: (2020)

Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types
por: Morisaki, Tamami, et al.
Publicado: (2021)

Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
por: Takada, Koji, et al.
Publicado: (2021)

CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Aomatsu, Naoki, et al.
Publicado: (2012)

Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2021)

Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma
por: Kashiwagi, Shinichiro, et al.
Publicado: (2013)

Adjunctive imprint cytology of core needle biopsy specimens improved diagnostic accuracy for breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2013)

Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d4384kpig4vumj6rvlosefh34o